June 26, 2008 (the “Letter Effective Date”)Collaboration Agreement • August 5th, 2008 • Exelixis Inc • Services-commercial physical & biological research
Contract Type FiledAugust 5th, 2008 Company IndustryPursuant to this letter agreement (this “Letter”), Exelixis and BMS desire to amend the Collaboration Agreement, effective as of January 11, 2007 (the “Agreement”), to allow for the [ * ]. Capitalized terms used in this Letter agreement that are not otherwise defined herein shall have the meanings given to them in the Agreement.
FOURTH AMENDMENT TO THE LOAN AND SECURITY AGREEMENT BETWEEN SMITHKLINE BEECHAM CORPORATION D/B/A GLAXOSMITHKLINE AND EXELIXIS, INC. EFFECTIVE OCTOBER 28, 2002.Loan and Security Agreement • August 5th, 2008 • Exelixis Inc • Services-commercial physical & biological research
Contract Type FiledAugust 5th, 2008 Company IndustryThis FOURTH AMENDMENT (the “Fourth Amendment”) is entered into as of July 10, 2008 (the “Fourth Amendment Effective Date”), by and between SMITHKLINE BEECHAM CORPORATION, a Pennsylvania corporation, d/b/a GlaxoSmithKline (“GSK”), and EXELIXIS, INC., a Delaware corporation (“EXEL”). EXEL and GSK are each referred to herein individually as a “Party” or, collectively, as the “Parties.”
SECOND AMENDMENT TO THE PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BETWEEN SMITHKLINE BEECHAM CORPORATION D/B/A GLAXOSMITHKLINE AND EXELIXIS, INC. DATED AS OF OCTOBER 28, 2002.Product Development and Commercialization Agreement • August 5th, 2008 • Exelixis Inc • Services-commercial physical & biological research
Contract Type FiledAugust 5th, 2008 Company IndustryThis SECOND AMENDMENT (the “Second Amendment”) is entered into as of June 13, 2008 (the “Second Amendment Effective Date”), by and between SMITHKLINE BEECHAM CORPORATION, a Pennsylvania corporation, doing business as GlaxoSmithKline (“GSK”), and EXELIXIS, INC., a Delaware corporation (“EXEL”). EXEL and GSK are each referred to herein individually as a “Party” or, collectively, as the “Parties.”
FIRST AMENDMENT TO LEASELease Agreement • August 5th, 2008 • Exelixis Inc • Services-commercial physical & biological research
Contract Type FiledAugust 5th, 2008 Company IndustryTHIS FIRST AMENDMENT TO LEASE (this “First Amendment”) is made as of May 31, 2008, by and between ARE-SAN FRANCISCO NO. 12, LLC, a Delaware limited liability company (“Landlord”), and EXELIXIS, INC., a Delaware corporation (“Tenant”).